Join

Compare · EXG vs HQH

EXG vs HQH

Side-by-side comparison of Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG) and abrdn Healthcare Investors Shares of Beneficial Interest (HQH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EXG and HQH operate in Finance Companies (Finance), so they compete in similar markets.
  • EXG is the larger of the two at $2.96B, about 3.3x HQH ($899.1M).
  • Both names hit the wire about 2 times in the past 4 weeks.
MetricEXGHQH
Company
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
abrdn Healthcare Investors Shares of Beneficial Interest
Price
-
-
Market cap
$2.96B
$899.1M
1M return
-
-
1Y return
-
-
Industry
Finance Companies
Finance Companies
Exchange
NYSE
NYSE
IPO
2007
1987
News (4w)
2
2
Recent ratings
0
0
EXG

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

Eaton Vance Tax-Managed Global Diversified Equity Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying stocks of companies. The fund also invests through derivatives. It also writes call options on one or more U.S. and foreign indices with respect to a portion of the value of its common stock portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index. Eaton Vance Tax-Managed Global Diversified Equity Income Fund was formed on February 27, 2007 and is domiciled in the United States.

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Latest EXG

Latest HQH